As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...

2 Dividend Stocks to Buy Hand Over Fist in November was originally published by The Motley Fool Their recent issues are ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Wednesday’s business headlines INDIANAPOLIS (WISH) — Here is a look at Wednesday’s business headlines with Jane ...

The report includes market projections, regulatory information, and updates on new products and technologies. It also ...

Amgen, a global biotechnology leader highlighting profound research and development capabilities and biomanufacturing, showcases its latest achievements in the field of innovative medicines under the ...

Discovery or identification of new product candidates or development of new indications for existing products ... Drug Administration, and no conclusions can or should be drawn regarding the safety or ...

At the CIIE, Amgen brings six innovative products-focusing on cardiovascular ... have been included in China's National Reimbursement Drug List. At present, Amgen China's business has covered ...

These drugs are also being tested for Alzheimer ... company with a diverse portfolio of marketed and pipeline products. Amgen’s discovery pipeline had led the company to broaden its focus ...

These are independent reviews of the products mentioned ... vice president of research and development at Amgen. The FDA approved the drug in May based on preliminary results showing it helped ...